Insmed Inc
(LTS:0JAV)
$
100.27
+1.22 (+1.23%)
Market Cap: 21.46 Bil
Enterprise Value: 20.82 Bil
PE Ratio: 0
PB Ratio: 30.42
GF Score: 66/100 Insmed Inc at Bank of America Global Healthcare Conference Transcript
May 12, 2026 / 08:40PM GMT
Release Date Price:
$115.55
(+9.01%)
Jason Zemansky
Bofa Merrill Lynch Asset Holdings Inc - Analyst
(audio in progress) Zemansky. I'm one of the SMID cap analyst here at BofA, and thank you for joining us on -- this our first day, second half of our Healthcare Conference in Viva Las Vegas. Hope it's hot enough for everyone.
Very pleased to have join us right now, Will Lewis, Chair and CEO of Insmed. Will, thanks so much for joining us.
William Lewis
Insmed Inc - Chairman of the Board, Chief Executive Officer
It's a pleasure.
Questions & Answers
Jason Zemansky;William Lewis
Bofa Merrill Lynch Asset Holdings Inc - Analyst;Insmed Inc - Chairman of
Perfect. Let's dive right in. So last week, despite reporting remarkably strong BRINSUPRI numbers, sales of $208 million, up 44% sequentially, there were some concerns raised over the discontinuation rates. So thus far, can you comment on the discontinuation rates and how that tracks to your expectations? And I guess, relative to similar oral small modules.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot